论文信息 - 119. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Well Tolerated - 字舞流文

119. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Well Tolerated

E. Kerwin | J. Tica | N. Dezutter | N. Mesaros | C. Fogarty | M. David | I. Leroux-Roels | J. R. Guiñazú | C. Vandermeulen | B. Essink | C. Andrews | Katie Steenackers | J. Koch | L. Fissette | M. Davis